Redox-dependent remodeling of mitochondrial nucleoids contributes to bioenergetic decline during neuronal aging.
Abstract
Why mitochondria progressively fail in aging neurons remains a fundamental question in neurobiology. Although bioenergetic decline and oxidative stress are hallmarks of aging, whether redox signaling remodels mitochondrial nucleoids (mt-nucleoids) to impair neuronal bioenergetics remains unclear. Using aged mouse neurons and human induced pluripotent stem cell (iPSC)-derived neurons, we demonstrate that redox-driven mt-nucleoid remodeling underlies reduced mtDNA transcript abundance and bioenergetic decline. Combining minimal photon fluxes (MINFLUX) nanoscopy with single-molecule transcription mapping, we identify distinct mt-nucleoid architectures governed by mitochondrial transcription factor A (TFAM)-mediated mtDNA compaction. Aging-associated oxidative stress drives mt-nucleoid remodeling from compact, transcriptionally active structures toward decompacted forms with reduced mtDNA transcript abundance and impaired mitochondrial ATP production. This remodeling involves species-specific TFAM redox mechanisms: cysteine oxidation promotes human TFAM polymerization, whereas methionine oxidation weakens mouse TFAM-mtDNA interactions. Notably, expressing an oxidation-resistant TFAM variant restores mt-nucleoid organization, mtDNA transcript abundance, and ATP production in aged neurons, identifying mt-nucleoid architecture as a potential target for preserving neuronal bioenergetics during aging.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
The paper claims that redox-driven remodeling of mitochondrial nucleoids, mediated by species-specific TFAM oxidation, causes bioenergetic decline in aging neurons and that restoring nucleoid architecture via oxidation-resistant TFAM can reverse this decline. This is relevant because it identifies a specific molecular mechanism (mt-nucleoid architecture) underlying a fundamental aspect of cellular aging (bioenergetic failure) and proposes a direct intervention to restore function, rather than merely treating downstream symptoms.
Author of this paper? Send a correction.